Daniel Kimball

Daniel Kimball serves as the Head of Pharma for North America at CENTOGENE since December 2022, having previously held the position of Senior Director of Business Development. With a robust background in genetic diagnostics, Daniel's experience includes a role as Genetic Diagnostic Liaison at Spark Therapeutics, where a significant product launch for LUXTURNA took place. Daniel began at CENTOGENE in 2017 as a Senior Account Manager focused on the US Market Launch. Prior positions include Regional Account Manager at Courtagen Life Sciences, Molecular Diagnostic Consultant at Transgenomic, and various sales roles at Athena Diagnostics, Cypress Bioscience, UCB Pharma, and Paychex. Daniel holds a Bachelor of Science degree in Communication, with a minor in Business, from SUNY Brockport.